Skip to main content
Fig. 6 | BMC Endocrine Disorders

Fig. 6

From: Role of human organic cation transporter-1 (OCT-1/SLC22A1) in modulating the response to metformin in patients with type 2 diabetes

Fig. 6

a Effect of metformin on AMPK phosphorylation in mock, reference OCT-1 and mutant transfects: Representative ummunoblots showing the change in pAMPK expression by the presence/absence of metformin in HepG2 cells expressing vehicle control, reference OCT-1 and mutant OCT-1 constructs. The lower panel represents the effect of the same on the expression of β–actin protein used as a loading control. M1: 181C > T; M2; 1201G > A; M3: 1222A > G. b Graph showing normalised densitometric values for the metformin- treated and untreated mock, wild type cells and mutant cells  

Back to article page